Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S.
To examine the prevalence of chemotherapy-or radiotherapy-associated side effects and related treatment burden, and correlates of fatigue and missed work days among cancer patients.
Materials and methods
A cross-sectional survey was conducted using a dual sampling frame of 63,949 cancer patients (35,751 from an online panel and 28,198 from telephone listings) ≥18 years receiving chemotherapy and/or radiotherapy at the time of the survey or during the previous 12 months. Data were collected on cancer type, time since diagnosis, treatment side effects, visits, caregiver burden, missed work days, and sociodemographic characteristics. Data are presented only for patients receiving cancer treatment at the time of the survey.
Of the 15,532 patients (24%) who responded to the screening questionnaire, 1,572 met the eligibility criteria and 1,569 completed the survey; 814 received chemotherapy and/or radiotherapy at the time of the survey. The most common side effects were fatigue (80%), pain (48%), and nausea/vomiting (48%). Patients spent 4.5 h, on average, per visit to treat side effects. Approximately 43% of the patients were employed; of these, 78% were actively working. Employed patients missed, on average, 18 work days annually for side effect treatment. Females, younger and unemployed patients, and those with higher levels of anxiety and depression experienced more fatigue; patients with a greater number of side effects endured more missed work days.
In addition to the symptomatic experience of side effects, patients reported a considerable time burden for treatment. It is important to consider supportive care strategies that may effectively reduce side effects and their associated treatment burden.
KeywordsChemotherapy Side effects Fatigue Absenteeism Survey
- 4.Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, Scher HI, Schrag D (2006) Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 7:903–909PubMedCrossRefGoogle Scholar
- 9.Butt Z, Wagner LI, Beaumont JL, Paice JA, Straus JL, Peterman AH, Carro G, Von Roenn JH, Shevrin D, Cella D (2007) Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapy. Support Care Cancer (in press)Google Scholar
- 15.Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W (1998) Progress toward guidelines for the management of fatigue. Oncology (Willist Park N Y) 12:369–377Google Scholar
- 16.Cohen J (1988) Statistical power analysis for the behavioral sciences. Erlbaum, Hillsdale, NJGoogle Scholar
- 20.Derogatis LR (1993) Brief symptom inventory administration, scoring, and procedures manual. NCS Pearson, MinneapolisGoogle Scholar
- 24.Gabrilove JL, Perez EA, Tomita DK, Rossi G, Cleeland CS (2007) Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks. Cancer 110:1629–1640PubMedCrossRefGoogle Scholar
- 31.Kallich JD, Tchekmedyian NS, Damiano AM, Shi J, Black JT, Erder MH (2002) Psychological outcomes associated with anemia-related fatigue in cancer patients. Oncology (Willist Park N Y) 16:117–124Google Scholar
- 36.Mock V (2007) NCCN Guidelines (NCCN practice guidelines in oncology—cancer-related fatigue). Version 2.2007. NCCN Clinical Practice Guidelines in OncologyGoogle Scholar
- 38.National Center for Health Statistics (2007) 2005 NHIS questionnaire—sample adult. In: 2005 NHIS questionnaire. Available at ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Survey_Questionnaires/NHIS/2005/English/
- 42.Skarstein J, Aass N, Fossa SD, Skovlund E, Dahl AA (2000) Anxiety and depression in cancer patients: relation between the hospital anxiety and depression scale and the European organization for research and treatment of cancer core quality of life questionnaire. J Psychosom Res 49:27–34PubMedCrossRefGoogle Scholar
- 46.Tauer K, Zhu L, Fortner B (2004) The impact of anemia treatment visits on the patient and their caregiver. Proc Am Soc Clin Oncol 23:753 (Abstract 8114)Google Scholar
- 49.Tran KT, Stephens MK et al (2006) Impact of chemotherapy-induced anemia on economic and quality of life outcomes in adults with cancer. Blood 108:Abstract 3355Google Scholar